Geraldine  Henwood net worth and biography

Geraldine Henwood Biography and Net Worth

CEO of Baudax Bio
Gerri Henwood has served as our President, Chief Executive Officer and a director of the Company since November of 2019. From 2008 to December 2020, Ms. Henwood was the President, Chief Executive Officer and a director of Recro Pharma, Inc. (REPH), a company she founded in 2008. From 2006 to 2013, Ms. Henwood served as the President of Malvern Consulting Group, Inc., or MCG, a pharmaceutical incubator and consulting firm. Before founding MCG, Ms. Henwood was the President and Chief Executive Officer of Auxilium Pharmaceuticals, Inc. (formerly AUXL), or Auxilium, a biopharmaceutical company she founded in late 1999. From 1985 to 1999, Ms. Henwood was the founder and Chief Executive Officer of IBAH, Inc., or IBAH, a contract research organization listed on NASDAQ. Ms. Henwood began her career with Smith Kline & French, now part of GlaxoSmithKline plc. She rose through the ranks to be a brand manager, then the head of Regulatory and Medical Affairs for the U.S. business and then to the position of Group Director—Marketing in the International Pharmaceutical Division.

Ms. Henwood previously served on the board of directors of Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, from 2015 until its acquisition by La Jolla Pharmaceutical Company in June 2020. Before that, she served on the board of directors of Alkermes, Inc. and its successor company, Alkermes, plc, a global biopharmaceutical company, from 2003 until March 2015, and on the board of directors of MAP Pharmaceuticals, Inc., a biopharmaceuticals company, from 2004 until its acquisition by Allergan, Inc. in March 2013. Ms. Henwood also served on the compensation committee of the board of directors of Tetraphase Pharmaceuticals, Inc.

Ms. Henwood holds a B.S. in Biology from Neumann University.

What is Geraldine Henwood's net worth?

The estimated net worth of Geraldine Henwood is at least $52.91 as of December 15th, 2022. Ms. Henwood owns 2,427 shares of Baudax Bio stock worth more than $53 as of March 28th. This net worth estimate does not reflect any other investments that Ms. Henwood may own. Additionally, Ms. Henwood receives a salary of $633,250.00 as CEO at Baudax Bio. Learn More about Geraldine Henwood's net worth.

How old is Geraldine Henwood?

Ms. Henwood is currently 72 years old. There are 2 older executives and no younger executives at Baudax Bio. Learn More on Geraldine Henwood's age.

What is Geraldine Henwood's salary?

As the CEO of Baudax Bio, Inc., Ms. Henwood earns $633,250.00 per year. Learn More on Geraldine Henwood's salary.

How do I contact Geraldine Henwood?

The corporate mailing address for Ms. Henwood and other Baudax Bio executives is 490 LAPP ROAD, MALVERN PA, 19355. Baudax Bio can also be reached via phone at 484-395-2440 and via email at [email protected]. Learn More on Geraldine Henwood's contact information.

Has Geraldine Henwood been buying or selling shares of Baudax Bio?

Geraldine Henwood has not been actively trading shares of Baudax Bio during the last quarter. Most recently, on Thursday, December 15th, Geraldine Henwood bought 1,200 shares of Baudax Bio stock. The stock was acquired at an average cost of $2.55 per share, with a total value of $3,060.00. Following the completion of the transaction, the chief executive officer now directly owns 2,427 shares of the company's stock, valued at $6,188.85. Learn More on Geraldine Henwood's trading history.

Who are Baudax Bio's active insiders?

Baudax Bio's insider roster includes Arnold Baskies (Director), Richard Casten (CFO), Winston Churchill (Director), and Geraldine Henwood (CEO). Learn More on Baudax Bio's active insiders.

Geraldine Henwood Insider Trading History at Baudax Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2022Buy1,200$2.55$3,060.002,427View SEC Filing Icon  
9/22/2021Buy205$23.60$4,838.00View SEC Filing Icon  
5/7/2021Buy150$33.20$4,980.008,907View SEC Filing Icon  
See Full Table

Geraldine Henwood Buying and Selling Activity at Baudax Bio

This chart shows Geraldine Henwood's buying and selling at Baudax Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Baudax Bio Company Overview

Baudax Bio logo
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.02
Low: $0.02
High: $0.03

2 Week Range

Now: $0.02
Low: $0.01
High: $3.47

Volume

310,800 shs

Average Volume

281,029 shs

Market Capitalization

$1.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57